Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut
Open accessThe DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Abstract
The pathogenesis of inflammatory bowel disease (IBD) is multifactorial with data suggesting the role of a disturbed interaction between the gut and the intestinal microbiota. A defective mucosal barrier may result in increased intestinal permeability which promotes the exposition to luminal content and triggers an immunological response that promotes intestinal inflammation. IBD patients display several defects in the many specialized components of mucosal barrier, from the mucus layer composition to the adhesion molecules that regulate paracellular permeability. These alterations may represent a primary dysfunction in Crohn's disease, but they may also perpetuate chronic mucosal inflammation in ulcerative colitis. In clinical practice, several studies have documented that changes in intestinal permeability can predict IBD course. Functional tests, such as the sugar absorption tests or the novel imaging technique using confocal laser endomicroscopy, allow an in vivo assessment of gut barrier integrity. Antitumor necrosis factor-α (TNF-α) therapy reduces mucosal inflammation and restores intestinal permeability in IBD patients. Butyrate, zinc, and some probiotics also ameliorate mucosal barrier dysfunction but their use is still limited and further studies are needed before considering permeability manipulation as a therapeutic target in IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Confocal laser endomicroscopy images from a healthy subject (a) and an Ulcerative Colitis (UC) patient with inactive disease (b). UC patients display increased crypt diameter, intercryptic distance, and perivascular fluorescence. Courtesy of Dr. A. Buda and with permission of Journal of Crohn's and Colitis [105]; © inclusion under a Creative Commons license or any other open-access license allowing onward reuse is prohibited.](https://figures.cochat.ai/paper-figures/2164d4b5b56e4db78a431b3045efb19f/intestinal-permeability-in-inflammatory-bowel-disease-pathogenesis-clinical-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This condition, known as intestinal permeability or leaky gut, has been implicated in the pathophysiology of various GI, as well as extraintestinal disorders [120,121,122], including PD [117,123,124,125,126,127,128]”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591 · cited 5×
“As a matter of fact several defects in bacterial recognition and processing have been documented in CD patients carrying particular genetic polymorphisms, chiefly of pattern-recognition receptors such as NOD2/CARD15 [68, 69] and genes involved in autophagy like ATG16L1 and IRGM [70–72].”
BackgroundInfluentialA frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Interactions Between the Microbiota and the Immune System
Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012) · Science · doi:10.1126/science.1223490 · Cited by 4,173 · cited 1×
“[9] “permeability” is defined as a functional feature of this barrier that on one hand allows the coexistence with bacterial symbionts necessary for our organism and on the other hand prevents luminal penetration of macromolecules and pathogens [10, 11].”
BackgroundReview article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Genetics and pathogenesis of inflammatory bowel disease
Khor, B., Gardet, A., & Xavier, R. J. (2011) · Nature · doi:10.1038/nature10209 · Cited by 2,614
MICROBIAL ECOLOGY OF THE GASTROINTESTINAL TRACT
Savage, D. C. (1977) · Annual Review of Microbiology · doi:10.1146/annurev.mi.31.100177.000543 · Cited by 2,436 · cited 1×
“It is estimated that the total bacterial cell count in our body exceeds ten times the total number of human cells, with more than one thousand species hosted in the gastrointestinal tract [1, 2].”
BackgroundMachiels, K., Joossens, M., Sabino, J., De Preter, V., Arijs, I., Eeckhaut, V., Ballet, V., Claes, K., Van Immerseel, F., Verbeke, K., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304833 · Cited by 1,904 · cited 1×
“Another potential mechanism of action is the restoration of butyrate-producing bacteria: UC patients have reduced bacterial species like Faecalibacterium prausnitzii [133, 139] and supplementation with butyrate-producing species or probiotics along with preformed butyrate showed efficacy in experimental models [140, 1…”
BackgroundHampe, J., Franke, A., Rosenstiel, P., Till, A., Teuber, M., Huse, K., Albrecht, M., Mayr, G., De La Vega, F. M., Briggs, J., et al. (2007) · Nature Genetics · doi:10.1038/ng1954 · Cited by 1,897
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775 · cited 1×
“The mechanical cohesion of these cells and the regulation of paracellular permeability of ions and smallmolecules are ensured by three types of junctional complexes, namely, tight junctions (TJs), adherence junctions, and desmosomes [24, 26, 27].”
BackgroundIntestinal permeability – a new target for disease prevention and therapy
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J.-D., Serino, M., Tilg, H., Watson, A., & Wells, J. M. (2014) · BMC Gastroenterology · doi:10.1186/s12876-014-0189-7 · Cited by 1,755 · cited 6×
“Both the probes are equally affected by gastrointestinal dilution, motility, bacterial degradation, and renal function; thus, the ratio allows for correcting possible confounding factors [9, 82].”
BackgroundInfluential
Research works printed but not linked: 1
- D'Incà R. Di Leo V. Martines D. Can permeability to sugars predict relapses in Crohn's disease? Gut 1993 34 1, supplement S50 S73
Cited by
Items 301–400 of 759
Li, P., Wang, Y., Li, P., Chen, X., Liu, Y., Zha, L., Zhang, Y., & Qi, K. (2022) · Nutrition · doi:10.1016/j.nut.2022.111837 · Cited by 23
Vermandere, K., Bostick, R. M., Tran, H. Q., Gewirtz, A. T., Barry, E. L., Rutherford, R. E., Seabrook, M. E., & Fedirko, V. (2020) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-20-0461 · Cited by 23
Zhu, W., Cremonini, E., Mastaloudis, A., & Oteiza, P. I. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103359 · Cited by 23
Kropp, C., Tambosco, K., Chadi, S., Langella, P., Claus, S. P., & Martín, R. (2024) · npj Biofilms and Microbiomes · doi:10.1038/s41522-024-00540-6 · Cited by 22
Um, C. Y., Hodge, R. A., Tran, H. Q., Campbell, P. T., Gewirtz, A. T., & McCullough, M. L. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.1957947 · Cited by 24
“Intestinal barrier dysfunction leading to increased intestinal permeability has been linked to various gastrointestinal diseases, including inflammatory bowel disease (1), celiac disease (2), and colorectal carcinogenesis (3).”
BackgroundUptake and Advanced Therapy of Butyrate in Inflammatory Bowel Disease
Ota, S., & Sakuraba, H. (2022) · Immuno · doi:10.3390/immuno2040042 · Cited by 26
Li, Y., Ma, M., Wang, X., Li, J., Fang, Z., Li, J., Yang, B., Lu, Y., Xu, X., & Li, Y. (2024) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2023.2300508 · Cited by 22
“Several clinical studies have shown increased intestinal permeability in UC [14,15].”
BackgroundDual action tofacitinib-loaded PLGA nanoparticles alleviate colitis in an IBD mouse model
Seegobin, N., McCoubrey, L. E., Vignal, C., Waxin, C., Abdalla, Y., Fan, Y., Awad, A., Murdan, S., & Basit, A. W. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01736-1 · Cited by 24
“In this study, we aim to load TFC into poly(lactic-co-glycolic acid) (PLGA) NPs to achieve this targeted delivery [21–23].”
Gut Microbiome Implication and Modulation in the Management of Recurrent Urinary Tract Infection
Brigida, M., Saviano, A., Petruzziello, C., Manetti, L. L., Migneco, A., & Ojetti, V. (2024) · Pathogens · doi:10.3390/pathogens13121028 · Cited by 22
Immunity‐on‐a‐Chip: Integration of Immune Components into the Scheme of Organ‐on‐a‐Chip Systems
Ramadan, Q., Hazaymeh, R., & Zourob, M. M. (2023) · Advanced Biology · doi:10.1002/adbi.202200312 · Cited by 23
Yang, J., Jie, L., Gu, T., Sun, Q., Xu, W., & Peng, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020841 · Cited by 22
“It is widely recognized that the gut harbors a vast number of bacteria that play pivotal roles in nutrition, energy metabolism, host defense, and immune system development [39].”
BackgroundThe Gut Microbiota and the Emergence of Autoimmunity: Relevance to Major Psychiatric Disorders
Severance, E. G., Tveiten, D., Lindström, L., Yolken, R. H., & Reichelt, K. L. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160914183804 · Cited by 22
Auzoux, J., Boschetti, G., Anon, B., Aubourg, A., Caulet, M., Poisson, L., Besson, P., Lecomte, T., Roger, S., Picon, L., et al. (2019) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2019.02.030 · Cited by 23
Ma, Y., Yin, Z., Li, L., Chen, B., Dai, H., Wu, D., Cong, J., Ye, L., Liao, C., Li, L., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107670 · Cited by 22
Li, S., Ma, B., Wang, J., Peng, H., Zheng, M., Dai, W., & Liu, J. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06319 · Cited by 21
‘All disease begins in the gut’—the role of the intestinal microbiome in ankylosing spondylitis
Harkins, P., Burke, E. P., Swales, C. E., & Silman, A. J. (2021) · Rheumatology Advances in Practice · doi:10.1093/rap/rkab063 · Cited by 22
Wu, S., Chen, W.-J., Chang, J. P., Guu, T., Hsin, M.-C., Huang, C., Mischoulon, D., Capuron, L., & Su, K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13061003 · Cited by 21
Mucosa‐Mimetic Materials for the Study of Intestinal Homeostasis and Disease
Donahue, R., Sahoo, J. K., Rudolph, S., Chen, Y., & Kaplan, D. L. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202300301 · Cited by 21
Marino, M., Venturi, S., Rendine, M., Porrini, M., Gardana, C., Klimis‐Zacas, D. J., Bo’, C. D., & Riso, P. (2023) · Food & Function · doi:10.1039/d3fo00835e · Cited by 20
Rong, S., Zhang, L., Wang, J., & Dong, H. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122326 · Cited by 20
The proteolytic activity in inflammatory bowel disease: insight from gut microbiota
Hou, J., Ding, L., Yang, T., Yang, Y.-F., Jin, Y., Zhang, X., Ma, A.-H., & Qin, Y. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106560 · Cited by 21
Blockade of PLD2 Ameliorates Intestinal Mucosal Inflammation of Inflammatory Bowel Disease
Zhou, G., Lin, Y., Yang, W., Wu, W. H., Fang, L., & Liu, Z. (2016) · Mediators of Inflammation · doi:10.1155/2016/2543070 · Cited by 20
Glyphosate pathways to modern diseases VI: Prions, amyloidoses and autoimmune neurological diseases
Samsel, A., & Seneff, S. (2017) · Journal of Biological Physics and Chemistry · doi:10.4024/25sa16a.jbpc.17.01 · Cited by 20
Cesarean section increases sensitivity to oxazolone-induced colitis in C57BL/6 mice
Zachariassen, L. F., Hansen, A. K., Krych, Ł., Nielsen, D. S., Holm, T. L., Tougaard, P., & Hansen, C. H. F. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0207-8 · Cited by 20
Polysorbate 80‐induced leaky gut impairs skeletal muscle metabolism in mice
Nishimura, S., Aoi, W., Kodani, H., Kobayashi, Y., Wada, S., Kuwahata, M., & Higashi, A. (2020) · Physiological Reports · doi:10.14814/phy2.14629 · Cited by 22
LRRK2: Genetic mechanisms vs genetic subtypes
Mata, I. F., Salles, P. A., Cornejo‐Olivas, M., Awad, P. S., Ross, O. A., Reed, X., & Bandrés‐Ciga, S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-85555-6.00018-7 · Cited by 20
Matrix-wise evaluation of in vivo and in vitro efficiencies of L. rhamnosus GG-fortified beverages
Sireswar, S., & Dey, G. (2018) · Food Research International · doi:10.1016/j.foodres.2018.10.077 · Cited by 19
Vermeer, E., Jagt, J. Z., Lap, E. M., Struys, E. A., Budding, A. E., Verhoeven‐Duif, N. M., Bosma, M., Limbergen, J. V., Koot, B. G. P., de Jonge, R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2517828 · Cited by 19
“31 Several studies have shown that a disruption of the mucosal barrier and thus increased permeability may occur early in IBD pathogenesis, 32,33 and microbial dysbiosis in IBD may further contribute to and maintain the intestinal barrier dysfunction.”
Lee, S. H., Goo, T., & Yun, E. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113786 · Cited by 20
Li, F., Huang, H., Zhao, P., Jiang, J., Ding, X., Lu, D., & Ji, L. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5310 · Cited by 18
“TNF‑ α serves a key role in the inflammatory cascade response that induces chronic intestinal inflammation in IBD (29).”
InfluentialLiu, W., Li, K., Yu, S., Wang, Z., Li, H., & Liu, X. (2024) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2023.2295224 · Cited by 18
Wu, Y., & Shen, J. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.10.003 · Cited by 23
Mahdy, R. N. E., Nader, M. A., Helal, M. G., Abu-Risha, S. E.-S., & Abdelmageed, M. E. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03631-5 · Cited by 20
Wang, Y., Liang, K., & Kong, W.-Z. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.03.004 · Cited by 20
De Novo Crohn's Disease Triggered After COVID-19: Is COVID-19 More Than an Infectious Disease?
Senthamizhselvan, K., Ramalingam, R., Mohan, P., Kavadichanda, C. G., Badhe, B. A., & Hamide, A. (2021) · ACG Case Reports Journal · doi:10.14309/crj.0000000000000652 · Cited by 20
Tuber flours improve intestinal health and modulate gut microbiota composition
Xu, T., Huang, W., Liang, J., Zhong, Y., Chen, Q., Jie, F., & Lu, B. (2021) · Food Chemistry X · doi:10.1016/j.fochx.2021.100145 · Cited by 20
Ma, G., Chen, Z., Xie, Z., Liu, J., & Xiao, X.-M. (2025) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2025.104423 · Cited by 19
He, X.-Y., Gao, Z.-Y., Liang, W., & Sun, Y.-C. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-5467 · Cited by 18
FOXO3 Deficiency in Neutrophils Drives Colonic Inflammation and Tumorigenesis
Ghimire, J., Iftikhar, R., Penrose, H. M., Snarski, P., Ruiz, E. M., & Savkovic, S. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119730 · Cited by 17
“function in the intestine, allowing for the presence of microbiota products [16,17], which can further foster tumorigenic processes in colonic cells.”
BackgroundDiabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity
Francis, K. L., Alonge, K. M., Pacheco, M. C., HU, S. J. W., KRUTZSCH, C. A., Morton, G. J., Schwartz, M. W., & Scarlett, J. M. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i33.4991 · Cited by 18
“Notably, both IBD and metabolic syndrome (of which T2D and DIO comprise two of the principle components) are associated with an altered gut microbiome, chronic systemic inflammation, and intestinal barrier dysfunction[4,22,23].”
Wang, L., Song, X., Zhou, Y., Xia, Y., Yang, Z., Chen, X., Shi, R., Geng, Z., Zhang, X., Wang, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112140 · Cited by 22
Kaiser, K. N., Snyder, J. R., Koppes, R. A., & Koppes, A. N. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202409718 · Cited by 17
Carreras, J., Roncador, G., & Hamoudi, R. (2024) · Cancers · doi:10.3390/cancers16244230 · Cited by 19
Adiliaghdam, F., Almpani, M., Gharedaghi, M. H., Najibi, M., Hodin, R. A., & Rahme, L. G. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10071 · Cited by 19
“Following deregulation of the intestinal barrier integrity, microbial paracellular transport out of the lumen cues an inflammatory response from the intestinal mucosa (34).”
BackgroundIn vivo labeling of epithelial cell–associated antigen passages in the murine intestine
Knoop, K. A., Kulkarni, D. H., McDonald, K. G., Gustafsson, J. K., Davis, J. E., Floyd, A. N., & Newberry, R. D. (2020) · Lab Animal · doi:10.1038/s41684-019-0438-z · Cited by 17
Cho, J., Kim, D., & Kang, H. (2020) · Life · doi:10.3390/life10090200 · Cited by 18
“The leading hypothesis for IBD is that an interaction between environmental and immune factors triggers disruption of intestinal barrier integrity, resulting in an exaggerated immune response to the commensal bacterial resident in the gut lumen [2] and chronic activation and inflammation in the intestinal immune syste…”
BackgroundTian, Y., & Zhang, D. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/2939921 · Cited by 17
“Previous studies have identified defects in many specific components of the gut barrier in IBD patients, ranging from the composition of the mucus layer to adhesion molecules that regulate paracellular permeability, and these alterations contribute to the persistence of chronic mucosal inflammation [19], which is also…”
BackgroundBüttner, J., Schneider, T. L., Westermann, M., & Glei, M. (2022) · Toxics · doi:10.3390/toxics10030130 · Cited by 18
Cai, Q., Kim, M. S., Harada, A., Idowu, M. O., Sundaresan, G., Zweit, J., & Oh, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213737 · Cited by 18
Actis, G. C., Pellicano, R., & Ribaldone, D. G. (2018) · Reviews on Recent Clinical Trials · doi:10.2174/1574887113666180910120959 · Cited by 16
Chiriac, S. A., Sfarti, C. V., Minea, H. O., Stanciu, C., Cojocariu, C., Sîngeap, A.-M., Gîrleanu, I., Cuciureanu, T., Petrea, O. C., Huiban, L., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13071230 · Cited by 20
Wang, B., Zhang, D., Zhang, T., Sutcharitchan, C., Hua, J., Hua, D., Zhang, B., & Li, S. (2023) · Chinese Medicine · doi:10.1186/s13020-023-00781-1 · Cited by 16
“Besides, biomolecules like IL-4, IFN-γ and TNF-α induced epithelial barrier disorder [28, 29] was important since intact skin and mucosal barriers are crucial for the maintenance of tissue homeostasis [30–32].”
BackgroundInfluentialHuang, Y., Wang, Z., Li, J., Bai, S., Shen, B. Q., Du, J., Xia, X., & Wang, F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.070 · Cited by 16
Zhang, X., Ma, L., Zhang, C., Hou, B., Zhou, Y., & Yu, S. (2020) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2020.10.008 · Cited by 16
Park, J., Choi, T. J., Kang, K. S., & Choi, S.-H. (2021) · Biomolecules · doi:10.3390/biom11020284 · Cited by 16
“Conversely, patients with ileal CD have relatively low abundance of Paneth cells that produce α-defensins and additional AMPs such as lysozymes and secretory phospholipase A2 [16,19].”
BackgroundInfluentialShirazinia, R., Golabchifar, A. A., & Fazeli, M. R. (2021) · Korean Journal of Pediatrics · doi:10.3345/cep.2020.01676 · Cited by 17
Kiron, V., Hayes, M., & Avni, D. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.09.012 · Cited by 17
Łoniewski, I., Szulińska, M., Kaczmarczyk, M., Podsiadło, K., Styburski, D., Skonieczna‐Żydecka, K., & Bogdański, P. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03801-0 · Cited by 18
“The gut microbiota plays an essential role in regulating the intestinal permeability of the intestinal mucosa, and a change in the microbiota community affects the mucosal barrier function of the gut [46, 47].”
BackgroundCosta, C. A. R. A., Quaglio, A. E. V., & Stasi, L. C. D. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.10.009 · Cited by 16
“The balancing act necessary to maintain intestinal homeostasis and alteration of the mucosal barrier function promotes the exposition to luminal content permeability and triggers an immunological response (Michielan and D'Inca, 2015; Sanchez de Medina et al., 2014).”
BackgroundVojdani, A., Vojdani, E., Herbert, M. R., & Kharrazian, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041381 · Cited by 16
“Even though neurological comorbidities are not frequently reported [10], incidences of psychiatric disorders were shown to be higher in patients with IBD [85–88].”
BackgroundHerrera, M., & Byerley, L. O. (2025) · Nutrients · doi:10.3390/nu17142373 · Cited by 15
“Metagenomic analyses further indicate that microbial communities in CD are enriched for genes involved in nitrogen respiration pathways, while UC samples tend to show increased expression of genes associated with oxidative stress and tight junction impairment [113].”
Liu, J., Fu, L., Yin, F., Yin, L., Song, X., Guo, H., & Liu, J. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00912 · Cited by 15
Gardey, E., Cseresnyés, Z., Sobotta, F. H., Eberhardt, J., Haziri, D., Grunert, P., Kuchenbrod, M. T., Gruschwitz, F. V., Hoeppener, S., Schümann, M., et al. (2023) · Small · doi:10.1002/smll.202306482 · Cited by 15
Tissue-resident bacteria in metabolic diseases: emerging evidence and challenges
Massier, L., Musat, N., Stümvoll, M., Tremaroli, V., Chakaroun, R., & Kovacs, P. L. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01065-0 · Cited by 15
“…former include, among others, pro-inflammatory cytokines (interferon gamma and tumour necrosis factor) that can modulate the expression and internalization of tight junction proteins, which are responsible for the connections between epithelial cells regulating the paracellular influx 46,47 (Fig.”
Zhang, Y., Xun, L., Qiao, R., Jin, S., Zhang, B., Luo, M., Wan, P., Zuo, Z., Song, Z., & Qi, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1478374 · Cited by 17
Hoffman, S., Cohen, N. A., Carroll, I. M., Tulchinsky, H., Borovok, I., Dotan, I., & Maharshak, N. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz086 · Cited by 17
Yao, Y., Feng, Q., & Shen, J. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1850269 · Cited by 16
Gargari, G., Taverniti, V., Bo’, C. D., Bernardi, S., Hidalgo‐Liberona, N., Meroño, T., Andrés‐Lacueva, C., Kroon, P. A., Cherubini, A., Riso, P., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02680-3 · Cited by 16
“Gut microbiota composition, IP, and inflammation are intimately linked and interact with each other contributing to the onset of numerous diseases such as obesity [3], rheumatoid arthritis [4], non-alcoholic fatty liver disease [5], cardiovascular diseases [6], inflammatory bowel disease [7], and psychiatric disorders…”
BackgroundLi, Y., Hu, J., Cheng, C., Xu, F., Au, R., Zhu, L., & Shen, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/2818136 · Cited by 21
“As the goal of UC treatment shifts towards mucosal healing [5, 6], rebuilding the mucosal barrier is essential for intestinal barrier protection.”
BackgroundSreedharan, S., Zouganelis, G. D., Drake, S. J., Tripathi, G., & Kermanizadeh, A. (2022) · Journal of Toxicology and Environmental Health Part B · doi:10.1080/10937404.2022.2153456 · Cited by 15
“However, since a defective mucosal barrier “leaky gut” is a main characteristic of IBD, (Michielan and D’Inca 2015) it seems logical that this might result in increased translocation of particulates into systemic circulation and subsequent adverse effects in humans.”
BackgroundHoffmann, M., Schwertassek, U., Seydel, A., Weber, K., Hauschildt, S., & Lehmann, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13985-x · Cited by 16
Scarlata, G. G. M., & Abenavoli, L. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2464037 · Cited by 15
Allergy and autoimmunity in children: non-mutually exclusive diseases. A narrative review
D’Auria, E., Minutoli, M., Colombo, A. I. M., Sartorio, M. U. A., Zunica, F., Zuccotti, G., & Lougaris, V. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1239365 · Cited by 17
Niu, L., Wang, S., Xu, Y., Zu, X., You, X., Zhang, Q., Zhuang, P., Jiang, M., Gao, J., Hou, X., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117825 · Cited by 14
Research progress of ferroptosis and inflammatory bowel disease
Ma, B., Hu, X., Ai, X., & Zhang, Y. (2024) · BioMetals · doi:10.1007/s10534-024-00604-2 · Cited by 14
“Many proteins including Zo-1, occludins, E-cadherin, and claudins, play an important role in maintaining the integrity of these tight junctions and mucosal barriers (Michielan 2015).”
Li, Z., Wan, M., Wang, M., Duan, J., & Jiang, S. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112416 · Cited by 17
A New Strategy in Modulating the Protease-Activated Receptor 2 (Par2) in Autoimmune Diseases
Khoon, L., & Piran, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010410 · Cited by 14
Barbosa, J. C., Machado, D., Almeida, D., Andrade, J. C., Brandelli, A., Gomes, A., & Freitas, A. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85170-1.00012-9 · Cited by 21
SZYMANSKA, E., BIERLA, J., Dądalski, M., Wierzbicka, A., KONOPKA, E., Cukrowská, B., & KIERKUS, J. (2022) · Minerva Gastroenterology · doi:10.23736/s2724-5985.22.03156-4 · Cited by 15
Microbial Composition and Stool Short Chain Fatty Acid Levels in Fibromyalgia
Kim, Y., Kim, G.-T., & Kang, J. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043183 · Cited by 15
“Elevated intestinal permeability is related to the inflammatory reaction of the bowels [22],”
BackgroundLevy, E. H., Marcil, V., Baumel, S. T. É., Dahan, N., DELVIN, E. E., & Spahis, S. (2023) · Nutrients · doi:10.3390/nu15061394 · Cited by 16
Dietary Zinc Intake and Inflammatory Bowel Disease in the French NutriNet-Santé Cohort
Vasseur, P., Dugelay, E., Benamouzig, R., Savoye, G., Herçberg, S., Touvier, M., Hugot, J., Julia, C., Lan, A., & Buscail, C. (2020) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000688 · Cited by 14
Mobbs, C. L., Darling, N. J., & Przyborski, S. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1357690 · Cited by 14
Qiu, Q., Geng, Z., Wang, L., Zuo, L., Deng, M., Zhang, H., Yang, Y., Wang, Y., Zhao, Z., Wen, H., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112380 · Cited by 13
Marino, M., Rendine, M., Venturi, S., Porrini, M., Gardana, C., Klimis‐Zacas, D. J., Riso, P., & Bo’, C. D. (2024) · Food & Function · doi:10.1039/d4fo01050g · Cited by 13
Adams, L., Li, X., Burchmore, R., Goodwin, R. J. A., & Wall, D. M. (2024) · Microbiology · doi:10.1099/mic.0.001504 · Cited by 14
“However, in diseases such as inflammatory bowel disease (IBD) where patients have an increased gut permeability, particularly during active disease, it is unclear whether an impaired barrier function is the result, or cause, of intestinal inflammation [6, 7].”
Zhao, L., Jiang, T., Zhang, Y., & Shen, Z. (2024) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.14037 · Cited by 13
Chronic Gastrointestinal Disorders and miRNA-Associated Disease: An Up-to-Date
Giammona, A., Galuzzi, B. G., Imperia, E., Gervasoni, C., Remedia, S., Restaneo, L., Nespoli, M., Gara, L. D., Tani, F., Cicala, M., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010413 · Cited by 14
“…mediators [182,183] or changes in gut microbiota, although the mechanisms are not as well understood as in IBD [179–181]. the expression tight junction proteins and inflammatory mediators [182,183] or changes in gut microbiota although the mechanisms are not as well understood as in IBD [179–181].”
The Regulation of Intestinal Inflammation and Cancer Development by Type 2 Immune Responses
Gámez‐Belmonte, R., Erkert, L., Wirtz, S. J., & Becker, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249772 · Cited by 16
van Lingen, E., Tushuizen, M. E., Steenhuis, M. E. J., van Deynen, T., Martens, J., Morales, D., Jong, A. E. V. D. M., Molendijk, I., van der Marel, S., & Maljaars, J. (2021) · International Journal of Colorectal Disease · doi:10.1007/s00384-021-04065-8 · Cited by 13
“In IBD patients, the intestinal barrier function is disrupted [11, 12].”
BackgroundLuo, P., Li, X., Gao, Y., Chen, Z., Zhang, Q., Wang, Z., & Tian, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.904926 · Cited by 13
“Pro-inflammatory cytokines have been proven to induce intestinal epithelial barrier dysfunction, which further augments the pathophysiological state of IBD (McGuckin et al., 2008; Michielan and D’Incà, 2015).”
BackgroundEffects of Milk Polar Lipids on DSS-Induced Colitis Severity Are Dependent on Dietary Fat Content
Garcia, C., Anto, L., & Blesso, C. N. (2022) · Nutrients · doi:10.3390/nu14235145 · Cited by 14
Kim, J. E., Song, H. J., Choi, Y. J., Jin, Y. J., Roh, Y. J., Seol, A., Park, S. H., Park, J. M., Kang, H., & Hwang, D. Y. (2023) · Laboratory Animal Research · doi:10.1186/s42826-022-00152-1 · Cited by 13
Wang, X., Shi, J., Xu, Z., Wang, D., Song, Y., Han, G., Wang, B., Cao, H., Liu, Y., & Hou, J. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102590 · Cited by 13
Dorshow, R. B., Johnson, J. R., Debreczeny, M. P., Riley, I. R., Shieh, J.-J. J., Rogers, T. E., Hall-Moore, C. M., Shaikh, N., Rouggly-Nickless, L. C., & Tarr, P. I. (2019) · Biomedical Optics Express · doi:10.1364/boe.10.005103 · Cited by 13
Jiang, Y., Zhang, C., & Wang, T. (2020) · Burns · doi:10.1016/j.burns.2020.11.004 · Cited by 13
Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery
Zhang, J., Liu, X., Lin, J., Bao, X., Peng, J., Gong, Z., Luan, X., & Chen, Y. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121979 · Cited by 13
Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn’s Disease
Kriger-Sharabi, O., & Kopylov, U. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072696 · Cited by 14
A microphysiological system for studying barrier health of live tissues in real time
Way, R., Templeton, H., Ball, D., Cheng, M.-H., Tobet, S. A., & Chen, T. W. (2024) · Communications Engineering · doi:10.1038/s44172-024-00285-2 · Cited by 12
Wang, Y., Xie, Z., Du, L., Wang, Q., Zhang, L., Wu, Y., & Han, J. (2024) · Food & Function · doi:10.1039/d4fo04873c · Cited by 12
Metadata
- Authors
- Michielan, A., & D’Incà, R.
- Affiliations
- University of Padua (IT)
- Corresponding author
- Michielan, Andrea
- ORCID
- Michielan, Andrea
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2015-01
- Volume
- 2015
- Issue
- 1
- Pages
- 628157-628157
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4637104
- OpenAlex
- W2176502392
- Cited by
- 709
- References
- 146
- Citations by year
- 2026: 61 · 2025: 54 · 2024: 86 · 2023: 91 · 2022: 99 · 2021: 82 · 2020: 81 · 2019: 58 · 2018: 38 · 2017: 37 · 2016: 21
- FWCI
- 4.05
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- University of Oxford
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal permeability, leaky gut, inflammatory bowel disease, Crohn's disease, ulcerative colitis, mucosal barrier dysfunction, gut microbiota, mucus layer, paracellular permeability, adhesion molecules, confocal laser endomicroscopy, butyrate, zinc, probiotics, intestinal inflammation
- MeSH terms
- Humans, Intestinal Mucosa, Permeability, Tumor Necrosis Factor-alpha, Zinc, Inflammatory Bowel Diseases, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.